Rainier Therapeutics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Rainier Therapeutics General Information

Description

Developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer. The company's technology uses Vofatamab, a human monoclonal antibody that targets and specifically blocks the activity of FGFR3 (fibroblast growth factor receptor 3), enabling medical practitioners to treat patients with early-stage and metastatic bladder cancer effectively.

Contact Information

Formerly Known As
BioClin Therapeutics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1040 Davis Street
  • Suite 202
  • San Leandro, CA 94577
  • United States
+1 (925)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1040 Davis Street
  • Suite 202
  • San Leandro, CA 94577
  • United States
+1 (925)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rainier Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 04-Mar-2021 Completed Out of Business
5. Later Stage VC 23-Jul-2019 Completed Generating Revenue
4. Early Stage VC (Series B) 30-Apr-2018 Completed Generating Revenue
3. Early Stage VC (Series A2) 04-Jun-2014 Completed Generating Revenue
2. Early Stage VC (Series A1) $16M $19M Completed Generating Revenue
1. Early Stage VC (Series A) 28-Dec-2012 $3M $3M Completed Generating Revenue
To view Rainier Therapeutics’s complete valuation and funding history, request access »

Rainier Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Rainier Therapeutics’s complete cap table history, request access »

Rainier Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer. The company'
Drug Discovery
San Leandro, CA
11 As of 2015

Waltham, MA
 

Framingham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rainier Therapeutics Competitors (65)

One of Rainier Therapeutics’s 65 competitors is Cogent Biosciences, a Formerly VC-backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cogent Biosciences Formerly VC-backed Waltham, MA
Xenetic Biosciences Corporation Framingham, MA
Kite Pharma Formerly VC-backed Santa Monica, CA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Meditope Biosciences Formerly VC-backed Pasadena, CA
You’re viewing 5 of 65 competitors. Get the full list »

Rainier Therapeutics Patents

Rainier Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018145120-A1 Methods, compositions, and kits for treatment of cancer Inactive 06-Feb-2017
WO-2016134234-A1 Methods, compositions, and kits for treatment of cancer Inactive 19-Feb-2015

Rainier Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rainier Therapeutics FAQs

  • When was Rainier Therapeutics founded?

    Rainier Therapeutics was founded in 2010.

  • Where is Rainier Therapeutics headquartered?

    Rainier Therapeutics is headquartered in San Leandro, CA.

  • What is the size of Rainier Therapeutics?

    Rainier Therapeutics has 11 total employees.

  • What industry is Rainier Therapeutics in?

    Rainier Therapeutics’s primary industry is Drug Discovery.

  • Is Rainier Therapeutics a private or public company?

    Rainier Therapeutics is a Private company.

  • What is Rainier Therapeutics’s current revenue?

    The current revenue for Rainier Therapeutics is .

  • How much funding has Rainier Therapeutics raised over time?

    Rainier Therapeutics has raised $99M.

  • Who are Rainier Therapeutics’s competitors?

    Cogent Biosciences, Xenetic Biosciences, Kite Pharma, Inovio Pharmaceuticals, and Meditope Biosciences are some of the 65 competitors of Rainier Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process